UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 289

Sortiert nach

Increased visit-to-visit blood pressure variability is associated with worse cardiovascular outcomes in low ejection fraction heart failure patients: Insights from the HEAAL study

International journal of cardiology, 2015-05, Vol.187, p.183-189

2015

Volltextzugriff (PDF)

Galectin-3 inhibition prevents adipose tissue remodelling in obesity

International Journal of Obesity, 2016-06, Vol.40 (6), p.1034-1038

2016

Volltextzugriff (PDF)

Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist

The Journal of pharmacology and experimental therapeutics, 2003-03, Vol.304 (3), p.1093

2003

Volltextzugriff (PDF)

Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study

International journal of cardiology, 2017-08, Vol.241, p.344-350

2017

Volltextzugriff (PDF)

Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes

Diabetes & metabolism, 2019-10, Vol.45 (5), p.429-435

2019

Volltextzugriff (PDF)

Blocking of Responses to Endotoxin by E5564 in Healthy Volunteers with Experimental Endotoxemia

The Journal of infectious diseases, 2003-02, Vol.187 (4), p.631-639

2003

Volltextzugriff (PDF)

Incident hyperkalemia may be an independent therapeutic target in low ejection fraction heart failure patients: Insights from the HEAAL study

International journal of cardiology, 2014-05, Vol.173 (3), p.380-387

2014

Volltextzugriff (PDF)

Temporal Trend and Time-Varying Effect of Preemptive Second Kidney Transplantation on Graft Survival: A 30-Year Single-Center Cohort Study

Transplantation proceedings, 2016-10, Vol.48 (8), p.2663-2668

2016

Volltextzugriff (PDF)

Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology

European heart journal, 2018-12, Vol.39 (48), p.4243-4254

2018

Volltextzugriff (PDF)

Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)

Journal of the American College of Cardiology, 2013-10, Vol.62 (17), p.1585-1593

2013

Volltextzugriff (PDF)

Continuous pharmacodynamic activity of eritoran tetrasodium, a TLR4 antagonist, during intermittent intravenous infusion into normal volunteers

Innate immunity (London, England), 2008-12, Vol.14 (6), p.383-394

2008

Volltextzugriff (PDF)

Saliva as a medium for aldosterone measurement in repeated sampling studies

Steroids, 2009-10, Vol.74 (10-11), p.853-858

2009

Volltextzugriff (PDF)

Extended in vivo pharmacodynamic activity of E5564 in normal volunteers with experimental endotoxemia [corrected]

The Journal of pharmacology and experimental therapeutics, 2004-01, Vol.308 (1), p.175

2004

Volltextzugriff (PDF)

A novel class of endotoxin receptor agonists with simplified structure, toll-like receptor 4-dependent immunostimulatory action, and adjuvant activity

The Journal of pharmacology and experimental therapeutics, 2002-02, Vol.300 (2), p.655

2002

Volltextzugriff (PDF)

Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS‐HF trial

European journal of heart failure, 2019-03, Vol.21 (3), p.345-351

2019

Volltextzugriff (PDF)

Salivary aldosterone as a diagnostic aid in primary aldosteronism

Hormone and metabolic research, 2010-06, Vol.42 (6), p.400

2010

Volltextzugriff (PDF)

Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative

European journal of heart failure, 2015-11, Vol.17 (11), p.1144-1151

2015

Volltextzugriff (PDF)

The relationship between repeated sprint ability and the aerobic and anaerobic energy systems

Journal of science and medicine in sport, 1998-06, Vol.1 (2), p.100-110

1998

Volltextzugriff (PDF)

Phase I Study of E7820, an Oral Inhibitor of Integrin α-2 Expression with Antiangiogenic Properties, in Patients with Advanced Malignancies

Clinical cancer research, 2011, Vol.17 (1), p.193-200

2011

Volltextzugriff (PDF)

E5531, a Pure Endotoxin Antagonist of High Potency

Science (American Association for the Advancement of Science), 1995-04, Vol.268 (5207), p.80-83

1995

Volltextzugriff (PDF)

Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS‐HF trial

European journal of heart failure, 2017-09, Vol.19 (9), p.1186-1197

2017

Volltextzugriff (PDF)

Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction

International journal of cardiology, 2018-12, Vol.272, p.260-266

2018

Volltextzugriff (PDF)

The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial Infarction

Journal of women's health (Larchmont, N.Y. 2002), 2022-03, Vol.31 (3), p.310

2022

Volltextzugriff (PDF)

Changes in Serum Potassium Levels During Hospitalization in Patients With Worsening Heart Failure and Reduced Ejection Fraction (from the EVEREST Trial)

The American journal of cardiology, 2015-03, Vol.115 (6), p.790-796

2015

Volltextzugriff (PDF)

1 – 25 von 289

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(226)
Mit Volltextzugriff
(173)

Publikationsform

Artikel
(289)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(205)
Science & Technology
(186)
Life Sciences & Biomedicine
(183)
Female
(161)
Middle Aged
(111)
Animals
(99)
Adult
(87)
Aged
(83)
Biological And Medical Sciences
(71)
Rats
(59)
Medical Sciences
(51)
Life Sciences
(35)
Adolescent
(33)
Cardiovascular System & Cardiology
(31)
Child
(30)
Aged, 80 And Over
(26)
Follow-Up Studies
(25)
Fundamental And Applied Biological Sciences. Psychology
(24)
Rats, Inbred Strains
(24)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Adherence to Antihypertensive Treatment and the Blood Pressure–Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial

Increased visit-to-visit blood pressure variability is associated with worse cardiovascular outcomes in low ejection fraction heart failure patients: Insights from the HEAAL study

Galectin-3 inhibition prevents adipose tissue remodelling in obesity

Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist

Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes

Blocking of Responses to Endotoxin by E5564 in Healthy Volunteers with Experimental Endotoxemia

Incident hyperkalemia may be an independent therapeutic target in low ejection fraction heart failure patients: Insights from the HEAAL study

Temporal Trend and Time-Varying Effect of Preemptive Second Kidney Transplantation on Graft Survival: A 30-Year Single-Center Cohort Study

Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology

Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)

Continuous pharmacodynamic activity of eritoran tetrasodium, a TLR4 antagonist, during intermittent intravenous infusion into normal volunteers

Saliva as a medium for aldosterone measurement in repeated sampling studies

Extended in vivo pharmacodynamic activity of E5564 in normal volunteers with experimental endotoxemia [corrected]

A novel class of endotoxin receptor agonists with simplified structure, toll-like receptor 4-dependent immunostimulatory action, and adjuvant activity

Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS‐HF trial

Salivary aldosterone as a diagnostic aid in primary aldosteronism

Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative

The relationship between repeated sprint ability and the aerobic and anaerobic energy systems

Phase I Study of E7820, an Oral Inhibitor of Integrin α-2 Expression with Antiangiogenic Properties, in Patients with Advanced Malignancies

E5531, a Pure Endotoxin Antagonist of High Potency

Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS‐HF trial

Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction

The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial Infarction

Changes in Serum Potassium Levels During Hospitalization in Patients With Worsening Heart Failure and Reduced Ejection Fraction (from the EVEREST Trial)

Aktive Filter

Suchergebnisse filtern